Stocktoria
LeonaBio, Inc. LONA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-18
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$102.3M | -$100.9M | -$125.5M | -$104.0M | -$64.0M |
| Net income | -$105.6M | -$96.9M | -$117.7M | -$95.6M | -$54.9M |
| Operating cash flow | -$45.7M | -$97.2M | -$100.8M | -$72.5M | -$43.1M |
| Free cash flow | — | -$97.2M | -$101.1M | -$73.6M | -$44.7M |
| Total assets | $92.2M | $58.8M | $160.2M | $258.2M | $332.0M |
| Total liabilities | $64.4M | $13.9M | $30.1M | $23.0M | $10.9M |
| Shareholders' equity | $27.8M | $44.8M | $130.2M | $235.1M | $321.1M |
| Ratios | |||||
| Return on assets | -114.6% | -164.9% | -73.4% | -37.0% | -16.5% |
| Return on equity | -380.0% | -216.2% | -90.4% | -40.7% | -17.1% |
| Current ratio | 1.88 | 4.18 | 5.37 | 9.68 | 28.07 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 64,222 | $660,202 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001620463 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.